A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
Active, not recruiting · NCT06436742 · Registry updated 2026-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, congenital myasthenic syndrome, hereditary disease, nervous system disorder, neuromuscular disease, neuromuscular junction disease | Active, not recruiting | Phase 1 | 2026-07-24 | NCT06436742 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| argenx | 52 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ann and Robert H Lurie Childrens Hospital of Chicago | Chicago | United States | 5 |
| CHU - Hospital de la Timone | Marseille | France | 2 |
| Clinical Trials Centre - South Eastern Health and Social Care Trust - The Ulster Hospital | Belfast | United Kingdom | 1 |
| Fondazione IRCCS Istituto Neurologico Carlo Besta | Milan | Italy | 35 |
| Group Hospitalier Pitie-Salpetriere | Paris | France | 1 |
| John Radcliffe Hospital - Oxford University Hospitals NHS Foundation Trust | Oxford | United Kingdom | 1 |
| Ottawa Hospital Research Institute - Civic Campus | Ottawa | Canada | 1 |
| UC Davis Medical Center | Sacramento | United States | 63 |
| Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur) | Valencia | Spain | 12 |